U.S. Retail REITs Stock News

Business Snapshot and Recent Share Performance Fidelity National Financial (FNF) offers title insurance, annuities, and life insurance products in the United States, with investors monitoring its recent share performance after a period of mixed returns. The stock recently closed at US$50.04, with total returns of 4.4% over the past month and 5.1% over the past 3 months, while year-to-date performance shows a decline of 7.8%. See our latest analysis for Fidelity National Financial. Recent...

IonQ partnered with the Jane Goodall Institute USA and FormationQ on a two-year research program using trapped-ion quantum computers. The collaboration focuses on modeling ecological factors and intergroup behaviors in chimpanzees and bonobos. This project is described as the first use of quantum-enhanced computation in ecological and behavioral sciences. IonQ (NYSE:IONQ) is drawing attention as it links its quantum computing platform to real-world ecological and behavioral research, an...

VNET Group (NasdaqGS:VNET) has drawn attention after recent share price pressure, with the stock down 13% over the past month and 14% over the past 3 months, which has sharpened the focus on its fundamentals. See our latest analysis for VNET Group. At the current share price of US$7.72, VNET Group’s recent 1 month share price return of down 13% and year to date share price return of down 15% contrast with a 3 year total shareholder return of about 2.8x. This suggests the stock’s previous...

Recently, Riot Platforms was assessed as trading materially above an estimated intrinsic value measure, raising questions about whether its current valuation is justified by fundamentals. Adding to these concerns, insiders have sold about US$8.4 million of stock over the past three months without any offsetting insider purchases, which some investors view as a cautionary signal. Next, we will examine how concerns about overvaluation and insider selling activity may influence Riot Platforms’...

AXIS Capital Holdings (NYSE:AXS) stock has drawn fresh attention after its recent trading performance, as investors weigh the insurer’s $114.52 share price against its earnings profile and current value score of 5. See our latest analysis for AXIS Capital Holdings. Recent trading reflects building momentum in AXIS Capital Holdings, with a 30-day share price return of 12.89% and a 90-day share price return of 15.21%, alongside a 1-year total shareholder return of 17.75% and a 5-year total...

Aehr Test Systems (AEHR) is back in focus as investors look ahead to its Q4 2026 earnings release and earnings call on July 14, with attention on backlog, silicon photonics orders and AI demand. See our latest analysis for Aehr Test Systems. Aehr Test Systems’ share price has recently pulled back, with a 1 day share price return of down 6.31% and a 30 day share price return of down 37.29%. However, its year to date share price return of 206.95% and very large 1 year total shareholder return...

Aon recently declared a quarterly cash dividend of US$0.820 per share payable on August 14, 2026, and made a series of leadership appointments across its reinsurance, consulting and PEO practices, alongside filing an omnibus shelf registration for various securities. Together, these moves highlight Aon’s focus on strengthening specialized expertise in areas like life consulting, casualty catastrophe risk and regional reinsurance platforms while preserving capital-raising flexibility. Next,...

TriCo Bancshares (TCBK) is back in focus after First Hawaiian, Inc. entered a definitive all stock agreement to acquire the California based bank in a transaction valued at about $2 billion. See our latest analysis for TriCo Bancshares. The takeover announcement has clearly reset expectations around TriCo Bancshares, with a 1-day share price return of 11.99% and a year-to-date share price return of 27.40% sitting alongside a 1-year total shareholder return of 43.90%. This points to strong,...

Quantum computing and advanced processing are moving from theory into real-world budgets, and US policy is now pointing serious money and attention at the companies involved. With new executive orders, funding plans, and government purchasing programs, the recent news matters for investors looking at quantum computing and advanced computing stocks. This article walks through 3 stocks from our Quantum Computing and Advanced Computing Stocks screener that are directly exposed to these...

SiTime (SITM) has secured a new senior secured revolving credit facility of up to US$200 million, giving the company additional liquidity for working capital, general corporate uses, and potential future transactions. See our latest analysis for SiTime. The new credit facility arrives after a sharp pullback, with SiTime’s 30 day share price return down 17.45%. However, the 90 day share price return of 35.09% and very large 1 year total shareholder return suggest momentum has been strong over...

CEO transition puts Brown-Forman in focus for investors Brown-Forman (BF.B) drew investor attention after announcing that longtime CEO and President Lawson Whiting will retire once a successor is appointed. The board has begun a formal internal and external search. See our latest analysis for Brown-Forman. The CEO transition news lands after a mixed share price pattern for Brown-Forman, with the stock up 1.9% over the past week but down about 10% on a 90 day share price basis, while the 5...

Hyatt Hotels Corporation, together with HSL Properties and Desert Hospitality Management, announced plans for the Hyatt Regency Tucson Convention Center, a 291-room, convention-focused hotel in downtown Tucson that is expected to open in late 2027 following a multi-million-dollar transformation. This first Hyatt Regency-branded property in Tucson is set to enlarge Hyatt’s meetings and events footprint in Southern Arizona, potentially reinforcing its positioning in the group and convention...

Old Dominion Freight Line (ODFL) is back in focus after Raymond James analyst Patrick Tyler Brown maintained an Outperform rating on the stock and raised his price target to $241 from $224. See our latest analysis for Old Dominion Freight Line. Old Dominion Freight Line’s share price has climbed 7.6% over the past week and 10.7% over the past 90 days, while the 1 year total shareholder return of 41.5% points to sustained momentum despite a softer 30 day share price return of 5.2%. If this...

Huntington Ingalls Industries (HII) drew fresh investor attention after christening the future USS George M. Neal (DDG 131), a Flight III Arleigh Burke-class destroyer built at its Ingalls Shipbuilding division. See our latest analysis for Huntington Ingalls Industries. Despite a steady flow of contract wins and program milestones across shipbuilding, unmanned systems and spectrum technologies, Huntington Ingalls Industries’ share price has come under pressure, with the 90 day share price...

Recently, Match Group reported ongoing challenges in acquiring new customers and weakening user engagement, with projections pointing to flat sales over the next 12 months and continued pressure on average revenue per user. This combination of slowing user growth, softer engagement, and cautious revenue expectations has heightened investor focus on the durability of Match Group’s core dating platforms and monetization model. We’ll now consider how concerns over flat sales and softer...

Wingstop (WING) has been under pressure over the past year, as the stock declined about 51% over that period and about 40% year to date, prompting investors to reassess what they are paying for future growth. See our latest analysis for Wingstop. At a share price of $154.06, Wingstop’s recent performance tells a story of fading momentum, with the stock down 22.22% on a 90 day share price return basis and total shareholder return over 1 year also declining 51.30%, despite a modest 5.48% gain...

In July 2026, NeoGenomics, Inc. launched PTEN IHC CDx, the first FDA-approved immunohistochemistry companion diagnostic for prostate adenocarcinoma, enabling identification of PTEN-deficient tumors in patients who may be eligible for AstraZeneca’s TRUQAP (capivasertib), with testing available across its national oncology laboratory network. This test not only extends NeoGenomics’ presence into urologic oncology but also deepens its role in personalized prostate cancer care through rapid,...

Aramark (ARMK) stock is in focus after the company was named to TIME's America's Best Companies 2026 list, a recognition tied to employee satisfaction, financial performance, and sustainability transparency. See our latest analysis for Aramark. The recognition comes as Aramark's share price has shown strong momentum, with a 31.56% 3 month share price return and a 58.97% year to date share price return, while the 5 year total shareholder return stands at 158.78%. If this kind of momentum has...

Oil tankers struck, air strikes in the Strait of Hormuz and talk of a naval blockade have pushed Brent crude 10% higher and raised fresh questions about how secure key trade routes really are. When shipping costs, insurance and route risks change this quickly, some Global Shipping and Logistics stocks can see meaningful shifts in expectations, both good and bad. This article focuses on 3 stocks from the screener that are directly exposed to the latest Middle East tension. Each one is...

Freedom Holding (FRHC) has just completed a US$300 million ordinary share offering, giving the company fresh capital as it advances its digital financial ecosystem and broadens its reach across Europe and the United States. See our latest analysis for Freedom Holding. The share price reaction has been mixed around these developments, with Freedom Holding down 3.2% on the day at US$160.82 but showing a 7 day share price return of 7.0% and a 1 month share price return of 16.4%. The 5 year total...

Eisai and Biogen (BIIB) have received U.S. FDA approval for LEQEMBI IQLIK, a once weekly subcutaneous autoinjector initiation dose for early Alzheimer’s. This enables at home treatment and offers an alternative to intravenous infusions. See our latest analysis for Biogen. Biogen’s share price has recently picked up, with a 1-day share price return of 4.96% and a 90-day share price return of 16.80%. The 1-year total shareholder return of 57.04% contrasts with weaker 3 and 5 year total...

Tariffs have shifted from headline politics to a real cost line for Main Street, and that ripple effect matters for your portfolio. Trump’s 2025 tariffs, higher input costs and rising small business pessimism are feeding into inflation pressures and uncertain demand. Some stocks tied closely to small business customers or imported goods now sit in the crosshairs of tighter margins and regulatory headaches. This article focuses on three stocks exposed to those tariff headwinds, all currently...

The federal court decision to void a US$1.8b IRS settlement linked to Donald Trump has pushed tax enforcement, legal risk, and regulatory oversight to the foreground again. For investors, that puts a fresh spotlight on regulated financial services and compliance firms that sit close to the flow of audits, investigations, and complex tax work. This article focuses on three stocks from our Regulated Financial Services & Compliance Firms screener that appear positioned to benefit from rising...

Compass Minerals International (CMP) has drawn fresh attention after a reduction in net leverage and an S&P credit rating upgrade, developments tied to expectations around salt cost normalization and improving Plant Nutrition margins. See our latest analysis for Compass Minerals International. At a share price of $29.53, Compass Minerals International’s recent 90 day share price return of 19.55% and year to date share price return of 48.69% point to building momentum, although the 5 year...